These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19404394)

  • 1. CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin.
    Friedman S; Lu M; Schultz A; Thomas D; Lin RY
    PLoS One; 2009; 4(4):e5395. PubMed ID: 19404394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
    Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
    PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
    Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
    Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers.
    Hardin H; Montemayor-Garcia C; Lloyd RV
    Hum Pathol; 2013 Sep; 44(9):1707-13. PubMed ID: 23528862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy.
    Ke CC; Liu RS; Yang AH; Liu CS; Chi CW; Tseng LM; Tsai YF; Ho JH; Lee CH; Lee OK
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):61-71. PubMed ID: 23081821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells.
    Meng X; Li M; Wang X; Wang Y; Ma D
    Cancer Sci; 2009 Jun; 100(6):1040-6. PubMed ID: 19385971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells.
    Friel AM; Zhang L; Curley MD; Therrien VA; Sergent PA; Belden SE; Borger DR; Mohapatra G; Zukerberg LR; Foster R; Rueda BR
    Reprod Biol Endocrinol; 2010 Dec; 8():147. PubMed ID: 21122138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of stem cell marker CD133 expression in colorectal cancer.
    Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F
    Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.
    O'Brien CA; Pollett A; Gallinger S; Dick JE
    Nature; 2007 Jan; 445(7123):106-10. PubMed ID: 17122772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
    Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
    Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133(+) cells isolated from various sources and their role in future clinical perspectives.
    Meregalli M; Farini A; Belicchi M; Torrente Y
    Expert Opin Biol Ther; 2010 Nov; 10(11):1521-8. PubMed ID: 20932225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.
    Liu J; Brown RE
    Int J Clin Exp Pathol; 2010 Oct; 3(8):755-62. PubMed ID: 21151388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of CD133(+) human colon cancer SW620 cells.
    Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
    Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization of metastatic anaplastic thyroid cancer stem cells.
    Li W; Reeb AN; Sewell WA; Elhomsy G; Lin RY
    PLoS One; 2013; 8(5):e65095. PubMed ID: 23724124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
    Chen KH; Hsu CC; Song WS; Huang CS; Tsai CC; Kuo CD; Hsu HS; Tsai TH; Tsai CY; Woung LC; Chiou SH; Lu KH; Chen YW
    Childs Nerv Syst; 2010 Nov; 26(11):1605-12. PubMed ID: 20526717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.